(NASDAQ: ALEC) Alector's forecast annual revenue growth rate of 2.49% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 106.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 26.17%.
Alector's revenue in 2025 is $81,130,000.On average, 11 Wall Street analysts forecast ALEC's revenue for 2025 to be $1,687,209,524, with the lowest ALEC revenue forecast at $1,145,419,927, and the highest ALEC revenue forecast at $1,971,110,107. On average, 11 Wall Street analysts forecast ALEC's revenue for 2026 to be $6,996,707,091, with the lowest ALEC revenue forecast at $418,006,919, and the highest ALEC revenue forecast at $20,436,793,472.
In 2027, ALEC is forecast to generate $7,887,375,587 in revenue, with the lowest revenue forecast at $1,190,256,989 and the highest revenue forecast at $24,719,087,112.